CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Angle Kappa +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04242875
NCT04242875N/ACompleted

Evaluation of Angle Kappa and Different Intraocular Lens Calculation Formulas in Acrysof® IQ Panoptix Intraocular Lens Outcomes, Visual Disturbances and Patient Satisfaction

Carolina Eyecare Physicians, LLC·observational·Posted Jan 27, 2020·Updated Mar 17, 2023

In Brief

An observational study evaluating Angle Kappa and Visual disturbance questionnaire. for Pseudophakia. Completed, enrolled 30 participants across 1 site.

Detailed Summary

Angle Kappa is considered a potential factor in explaining suboptimal outcomes with intraocular lenses (IOLs), particularly multifocal IOLs. Some evidence suggests this is not the case. This study was designed to investigate correlations between angle kappa and post-surgical outcomes with a trifocal IOL.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPseudophakia
CountriesUnited States
CollaboratorsScience in Vision

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 27, 2020
Enrollment StartJan 21, 2020
Primary CompletionApr 27, 2021
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 6.4 years ago

Interventions

Angle Kappaother

Angle kappa will be measured using the OPD III scan.

Visual disturbance questionnaire.other

Questionnaire evaluating visual disturbances.